These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 19809402)

  • 1. Combinatorial control of suicide gene expression by tissue-specific promoter and microRNA regulation for cancer therapy.
    Wu C; Lin J; Hong M; Choudhury Y; Balani P; Leung D; Dang LH; Zhao Y; Zeng J; Wang S
    Mol Ther; 2009 Dec; 17(12):2058-66. PubMed ID: 19809402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment.
    Balani P; Boulaire J; Zhao Y; Zeng J; Lin J; Wang S
    Mol Ther; 2009 Jun; 17(6):1003-11. PubMed ID: 19240692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies.
    Staquicini FI; Smith TL; Tang FHF; Gelovani JG; Giordano RJ; Libutti SK; Sidman RL; Cavenee WK; Arap W; Pasqualini R
    Cancer Gene Ther; 2020 May; 27(5):301-310. PubMed ID: 31130731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
    Okada Y; Okada N; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T
    Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial control of transgene expression by hypoxia-responsive promoter and microrna regulation for neural stem cell-based cancer therapy.
    Luo Y; Zhu D
    Biomed Res Int; 2014; 2014():751397. PubMed ID: 24864258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide micelle-mediated delivery of tissue-specific suicide gene and combined therapy with avastin in a glioblastoma model.
    Oh B; Han J; Choi E; Tan X; Lee M
    J Pharm Sci; 2015 Apr; 104(4):1461-9. PubMed ID: 25631673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of hypoxia and glioma dual-specific suicide gene using dexamethasone conjugated polyethylenimine for glioblastoma-specific gene therapy.
    Kim HA; Park JH; Yi N; Lee M
    Mol Pharm; 2014 Mar; 11(3):938-50. PubMed ID: 24467192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene.
    Skalsky RL; Cullen BR
    PLoS One; 2011; 6(9):e24248. PubMed ID: 21912681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapy.
    Suzuki T; Sakurai F; Nakamura S; Kouyama E; Kawabata K; Kondoh M; Yagi K; Mizuguchi H
    Mol Ther; 2008 Oct; 16(10):1719-26. PubMed ID: 18665157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector--potential glioblastoma targeting.
    McKie EA; Graham DI; Brown SM
    Gene Ther; 1998 Apr; 5(4):440-50. PubMed ID: 9614567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual systemic tumor targeting with ligand-directed phage and Grp78 promoter induces tumor regression.
    Kia A; Przystal JM; Nianiaris N; Mazarakis ND; Mintz PJ; Hajitou A
    Mol Cancer Ther; 2012 Dec; 11(12):2566-77. PubMed ID: 23053496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery.
    Volak A; LeRoy SG; Natasan JS; Park DJ; Cheah PS; Maus A; Fitzpatrick Z; Hudry E; Pinkham K; Gandhi S; Hyman BT; Mu D; GuhaSarkar D; Stemmer-Rachamimov AO; Sena-Esteves M; Badr CE; Maguire CA
    J Neurooncol; 2018 Sep; 139(2):293-305. PubMed ID: 29767307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors.
    Zhao Y; Lam DH; Yang J; Lin J; Tham CK; Ng WH; Wang S
    Gene Ther; 2012 Feb; 19(2):189-200. PubMed ID: 21633393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Therapy Using Neural Stem/Progenitor Cells Derived from Human Induced Pluripotent Stem Cells: Visualization of Migration and Bystander Killing Effect.
    Tamura R; Miyoshi H; Morimoto Y; Oishi Y; Sampetrean O; Iwasawa C; Mine Y; Saya H; Yoshida K; Okano H; Toda M
    Hum Gene Ther; 2020 Mar; 31(5-6):352-366. PubMed ID: 32075424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial promoter selectivity following AAV-delivery to the immature brain.
    von Jonquieres G; Mersmann N; Klugmann CB; Harasta AE; Lutz B; Teahan O; Housley GD; Fröhlich D; Krämer-Albers EM; Klugmann M
    PLoS One; 2013; 8(6):e65646. PubMed ID: 23799030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
    Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Restrictive Suicide Gene Therapy for Glioma Controlled by the FOS Promoter.
    Pan J; Wang H; Liu X; Hu J; Song W; Luo J; Jiang S; Yan F; Zhai B
    PLoS One; 2015; 10(11):e0143112. PubMed ID: 26571389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements.
    de Leeuw B; Su M; ter Horst M; Iwata S; Rodijk M; Hoeben RC; Messing A; Smitt PS; Brenner M
    J Neurosci Res; 2006 Apr; 83(5):744-53. PubMed ID: 16496373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
    Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD
    Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.